ArticlePloS one2025
A KAN-based hybrid deep neural networks for accurate identification of transcription factor binding sites.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Effects of Transcranial Electrical Stimulation on Intermuscular Coherence in WuShu Sprint and KAN-Based EMG-Performance Function Fitting.Sensors (Basel, Switzerland) · 2025Trial
- GeoPep: A Geometry-Aware Masked Language Model for Protein-Peptide Binding Site Prediction.Journal of chemical information and modeling · 2026Article
- Predicting the Punching Force in Wushu Sanda After Neuromuscular Electrical Stimulation by Employing the KAN Neural Network Combined with Neuromuscular Electricity.Sensors (Basel, Switzerland) · 2025Article
- Kolmogorov-Arnold networks for genomic tasks.Briefings in bioinformatics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPredicting protein-DNA binding sites in vivo is a challenging but urgent task in many fields such as drug design and development. Most promoters contain many transcription factor (TF) binding sites, yet only a few have been identified through time-consuming biochemical experiments. To address this challenge, numerous computational approaches have been proposed to predict TF binding sites from DNA sequences. However, current deep learning methods often face issues such as gradient vanishing as the model depth increases, leading to suboptimal feature extraction.
resultsWe propose a model called CBR-KAN (where C represents Convolutional Neural Network (CNN), B represents Bidirectional Long Short Term Memory (BiLSTM), and R represents Residual Mechanism) to predict transcription factor binding sites. Specifically, we designed a multi-scale convolution module (ConvBlock1, 2, 3) combined with BiLSTM network, introduced KAN network to replace traditional multilayer perceptron, and promoted model optimization through residual connections. Testing on 50 common ChIP seq benchmark datasets shows that CBR-KAN outperforms other state-of-the-art methods such as DeepBind, DanQ, DeepD2V, and DeepSEA in predicting TF binding sites.
conclusionsThe CBR-KAN model significantly improves prediction accuracy for transcription factor binding sites by effectively integrating multiple neural network architectures and mechanisms. This approach not only enhances feature extraction but also stabilizes training and boosts generalization capabilities. The promising results on multiple key performance indicators demonstrate the potential of CBR-KAN in bioinformatics applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.